Monoamine oxidase inhibition by the tremorogenic drug--LON 954
- J Pharm Pharmacol. 1984 Jun;36(6):408-10. doi: 10.1111/j.2042-7158.1984.tb04411.x.
PMID: 6146677
DOI: 10.1111/j.2042-7158.1984.tb04411.x
Abstract
N-Carbamoyl-2-(2,6-dichlorophenyl)acetamidine HCl (LON 954), a tremorogenic drug, inhibited MAO activity in various tissue preparations in a reversible, competitive manner showing some degree of selectivity towards type-B MAO.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Monoamine OxidaseResearch Areas: Neurological Disease